Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy

Background: Estimating distant recurrence (DR) risk among women with estrogen receptor–positive (ER+), human epidermal growth factor receptor 2 (HER2)–negative early breast cancer helps decisions on using adjuvant chemotherapy. The 21-gene Oncotype DX recurrence score (RS) is widely used for this. E...

Descripción completa

Detalles Bibliográficos
Autores principales: Buus, Richard, Sestak, Ivana, Kronenwett, Ralf, Denkert, Carsten, Dubsky, Peter, Krappmann, Kristin, Scheer, Marsel, Petry, Christoph, Cuzick, Jack, Dowsett, Mitch
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241904/
https://www.ncbi.nlm.nih.gov/pubmed/27400969
http://dx.doi.org/10.1093/jnci/djw149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241904/
https://www.ncbi.nlm.nih.gov/pubmed/27400969
http://dx.doi.org/10.1093/jnci/djw149

Ejemplares similares